Cross-protection conferred by the vaccine strain Eimeria maxima 013 against six heterologous pathogen strains

Home Knowledge Cross-protection conferred by the vaccine strain Eimeria maxima 013 against six heterologous pathogen strains

Cross-protection conferred by the vaccine strain Eimeria maxima 013 against six heterologous pathogen strains

The study was designed to assess the immunogenicity of the vaccine strain E. maxima 013 when administered in 1-day-old chicks (minimum recommended age for vaccination) against six heterologous pathogen strains from six very different geographic locations.

About this article

Authors

Pagès, M.; Dardi, M.; Rubio, J.

Summary

The results obtained with regard to protection (reduced oocyst excretion in faeces and reduced macroscopic lesions in the mid-intestine) demonstrate the suitability of the vaccine strain E. maxima 013 for protection against very different field strains.

Related services

Related products

Share this on